Exogenous Galactosylceramide as Potential Treatment for CLN3 Disease

Annals of Neurology
Sally El-SittRose-Mary Boustany

Abstract

CLN3 disease is the commonest of the neuronal ceroid lipofuscinoses, a group of pediatric neurodegenerative disorders. Functions of the CLN3 protein include antiapoptotic properties and facilitating anterograde transport of galactosylceramide from Golgi to lipid rafts. This study confirms the beneficial effects of long-term exogenous galactosylceramide supplementation on longevity, neurobehavioral parameters, neuronal cell counts, astrogliosis, and diminution in brain and serum ceramide levels in Cln3 Δex7/8 knock-in mice. Additionally, the impact of galactosylceramide on ceramide synthesis enzymes is documented. A group of 72 mice received galactosylceramide or vehicle for 40 weeks. The effect of galactosylceramide supplementation on Cln3 Δex7/8 mice was determined by performing behavioral tests, measuring ceramide in brains and serum, and assessing impact on longevity, subunit C storage, astrogliosis, and neuronal cell counts. Galactosylceramide resulted in enhanced grip strength of forelimbs in male and female mice, better balance on the accelerating rotarod in females, and improved motor coordination during pole climbing in male mice. Brain and serum ceramide levels as well as apoptosis rates were lower in galactosylceramid...Continue Reading

References

Jun 5, 1995·American Journal of Medical Genetics·T J LernerA J Buckler
Aug 1, 1996·Journal of Neurochemistry·S C LaneR M Boustany
Feb 1, 1997·Neuropediatrics·K PuranamR M Boustany
Aug 1, 1997·American Journal of Human Genetics·P B MunroeS E Mole
May 4, 2002·Molecular and Cellular Neurosciences·Gail M SeigelHannah M Mitchison
Aug 22, 2002·Human Molecular Genetics·Dixie-Ann N W Persaud-SawinRose-Mary N Boustany
Jan 17, 2003·Journal of Neuropathology and Experimental Neurology·Matti Haltia
Feb 13, 2003·Nucleic Acids Research·Rafael A IrizarryTerence P Speed
Jul 9, 2004·Pediatric Research·Dixie-Ann Persaud-SawinRose-Mary N Boustany
Sep 10, 2005·Apoptosis : an International Journal on Programmed Cell Death·D A Persaud-Sawin, R-M N Boustany
May 2, 2006·Statistical Applications in Genetics and Molecular Biology·Gordon K Smyth
Mar 5, 2008·Pediatric Research·Elena RusynRose-Mary N Boustany
Jun 13, 2008·Neurobiology of Aging·Xingxuan HeEdward H Schuchman
Feb 27, 2009·Genes, Brain, and Behavior·N S OsórioF Rodrigues
Sep 4, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michelle M MielkeConstantine G Lyketsos
Oct 6, 2010·Advances in Experimental Medicine and Biology·Christopher R GaultYusuf A Hannun
Dec 15, 2011·Journal of Inherited Metabolic Disease·Jennifer CialoneJonathan W Mink
Jan 15, 2013·The International Journal of Neuroscience·Peter J Ostergaard, Matthew B Jensen
Mar 7, 2019·Frontiers in Neurology·Sally El-SittRose-Mary Boustany

❮ Previous
Next ❯

Citations

Aug 17, 2020·Cells·Katia MaaloufRose-Mary Boustany

❮ Previous
Next ❯

Related Concepts

Related Feeds

Batten Disease

Batten Disease is a group of nervous system disorders known as neuronal ceroid lipofuscinosis. This feed focuses on neurobiological and neuropathological aspects of this disease.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
S E Mole
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
S E Mole
BioRxiv : the Preprint Server for Biology
Sophia-Martha Kleine HolthausRobin R Ali
© 2021 Meta ULC. All rights reserved